I. Dahiyat Bassil's most recent trade in Xencor Inc was a trade of 19,716 Common Stock done at an average price of $13.6 . Disclosure was reported to the exchange on March 10, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 13.60 per share. | 10 Mar 2025 | 19,716 | 465,419 (0%) | 0% | 13.6 | 268,080 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 329,236 | 329,236 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 109,745 | 485,135 (0%) | 0% | 0 | Common Stock | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.69 per share. | 03 Feb 2025 | 8,808 | 375,390 (0%) | 0% | 15.7 | 138,198 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2025 | 8,808 | 0 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.69 per share. | 21 Nov 2024 | 49,278 | 401,893 (0%) | 0% | 15.7 | 773,172 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2024 | 49,278 | 22,356 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 24.07 per share. | 21 Nov 2024 | 49,278 | 352,615 (0%) | 0% | 24.1 | 1,186,363 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Nov 2024 | 13,548 | 8,808 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.69 per share. | 21 Nov 2024 | 13,548 | 366,163 (0%) | 0% | 15.7 | 212,568 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 24.02 per share. | 13 Nov 2024 | 3,366 | 352,615 (0%) | 0% | 24.0 | 80,842 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.69 per share. | 13 Nov 2024 | 3,366 | 355,981 (0%) | 0% | 15.7 | 52,813 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2024 | 3,366 | 71,634 | - | - | Stock Option (Right to Buy) | |
Kodiak Sciences Inc | Bassil I. Dahiyat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 23.50 per share. | 11 Mar 2024 | 2,741 | 351,894 (0%) | 0% | 23.5 | 64,418 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 327,225 | 327,225 | - | - | Stock Options | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 54,538 | 354,635 (0%) | 0% | 0 | Common Stock | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 23.43 per share. | 05 Mar 2024 | 12,528 | 300,097 (0%) | 0% | 23.4 | 293,519 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Dec 2023 | 65,001 | 0 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | I. Dahiyat Bassil | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.05 per share. | 29 Dec 2023 | 65,001 | 357,929 (0%) | 0% | 11.0 | 718,261 | Common Stock |
Xencor Inc | Dahiyat I. Bassil | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 20.93 per share. | 29 Dec 2023 | 45,000 | 312,929 (0%) | 0% | 20.9 | 941,670 | Common Stock |
Kodiak Sciences Inc | Bassil I. Dahiyat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.25 per share. | 21 Jun 2023 | 76,012 | 325,713 (0%) | 0% | 4.3 | 323,051 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2023 | 76,012 | 0 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 26.19 per share. | 21 Jun 2023 | 33,497 | 292,216 (0%) | 0% | 26.2 | 877,286 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 29.88 per share. | 09 Mar 2023 | 2,602 | 249,701 (0%) | 0% | 29.9 | 77,746 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 31.42 per share. | 06 Mar 2023 | 5,831 | 252,303 (0%) | 0% | 31.4 | 183,186 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 315,126 | 315,126 | - | - | Stock Options | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 52,521 | 260,985 (0%) | 0% | 0 | Common Stock | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 31.54 per share. | 02 Mar 2023 | 2,851 | 258,134 (0%) | 0% | 31.5 | 89,915 | Common Stock |
Kodiak Sciences Inc | Bassil I. Dahiyat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 29.00 per share. | 09 Mar 2022 | 2,494 | 207,815 (0%) | 0% | 29 | 72,326 | Common Stock |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 298,567 | 298,567 | - | - | Stock Options | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 49,761 | 210,309 (0%) | 0% | 0 | Common Stock | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 29.90 per share. | 03 Mar 2022 | 2,929 | 160,548 (0%) | 0% | 29.9 | 87,581 | Common Stock |
Kodiak Sciences Inc | Bassil I. Dahiyat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 7,368 | 7,368 | - | - | Stock Option (Right to Buy) | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 131,993 | 131,993 | - | - | Stock Options | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2021 | 21,999 | 163,063 (0%) | 0% | 0 | Common Stock | |
Xencor Inc | Bassil I. Dahiyat | Director, PRESIDENT & CEO | Sale of securities on an exchange or to another person at price $ 44.88 per share. | 03 Mar 2021 | 2,850 | 141,064 (0%) | 0% | 44.9 | 127,909 | Common Stock |
Kodiak Sciences Inc | Bassil I. Dahiyat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 7,106 | 7,106 | - | - | Stock Option (Right to Buy) | |
Kodiak Sciences Inc | Bassil I. Dahiyat | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2020 | 4,135 | 4,135 | - | - | Stock Option (Right to Buy) |